CSI Market
Sign In | Register

Apellis Pharmaceuticals Inc (APLS) Annual Balance Sheets

Annual · GAAP · USD millions
Access APLS quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Apellis Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent466.23
Marketable Securities, Current SH0.00
Cash & Short-term Investments466.00
Accounts receivable366.22
Inventories142.56
Other Current Assets1.53
Prepaid Expense And Other Assets Current38.30
Total Current Assets1,014.84
Equipment/Property/Plant Net1.71
Other Assets, Noncurrent58.71
Restricted Cash Current1.53
Operating Lease Right Of Use Asset18.20
Total Assets1,075.26
Liabilities
Accounts Payable, Current AC56.80
Accrued Liabilities, Current AC166.05
Convertible Debt, Current LO93.66
Other Liabilities, Current0.00
Total Current Liabilities323.60
Long-term debt361.66
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt361.66
Other liabilities, Noncurrent7.90
Operating Lease Liability Current7.09
Operating Lease Liability Noncurrent11.95
Total Liabilities705.11
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock3,385.22
Retained Earnings / Accumulated Deficit-3,012.98
Other Equity-2.10
Common Stockholder's Equity370.15
Total Stockholder's Equity370.15
Liabilities & Stockholder's Equity1,075.26
4 historic quarters locked

Sign in to unlock the full Apellis Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Apellis Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: apls-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-065179

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.